A novel clinically relevant graft-versus-leukemia model in humanized mice

Area of Science:

• Immunology
• Hematology
• Oncology

Background:

• Prognosis for acute myeloid leukemia (AML) relapse post allogeneic hematopoietic stem cell transplantation (alloSCT) is poor.
• The graft-versus-leukemia (GVL) effect is crucial for alloSCT success, but mechanisms of leukemia immune escape are poorly understood.
• Existing models lack clinical relevance for studying human GVL responses against AML.

Purpose of the Study:

• To establish a novel, clinically relevant humanized mouse model for studying GVL response against human AML.
• To investigate the mechanisms underlying GVL failure and leukemia immune escape.
• To provide a platform for developing novel therapeutic strategies for AML.

Main Methods:

• Established humanized mice by injecting donor hematopoietic stem cells (HSCs) into immune-deficient NSG mice.
• Engrafted patient-derived, allogeneic but HLA partially matched AML cells into humanized mice.
• Compared leukemia growth in humanized mice with that in control NSG mice to assess GVL effect.

Main Results:

• Successfully established a humanized mouse model with immune reconstitution mirroring patient scenarios.
• Demonstrated a functional, albeit defective, GVL effect in humanized mice, evidenced by reduced leukemia growth.
• Observed significantly reduced leukemia growth in humanized mice compared to control mice.

Conclusions:

• A novel humanized mouse model for studying human GVL against AML has been successfully established.
• This model recapitulates key aspects of GVL response and failure in vivo.
• The model serves as a valuable platform for future research into AML mechanisms and treatment development.